Capital Export organizes a primary MBO on Verdot IPS²
Capital Export, an investment fund specializing in supporting exporting companies, is organizing a primary MBO for Verdot IPS², a French company designing equipment that enables pharmaceutical players (Big Pharma, biotechs, etc.) to extract active ingredients for the manufacture of drugs and vaccines. Alongside Capital Export as the majority shareholder, Éric Merlot (incumbent CEO), Swen Capital, CEPAL Capital (Caisse d’Epargne Auvergne-Limousin), and CELDA Capital (Caisse d’Epargne Loire-Drôme-Ardèche) are participating in the funding round.